Table 2. Summary of disconcordant West Nile and dengue virus neutralizing antibody results between the New York multiplex microsphere assay (NY—MIA) and the University of Texas at El Paso plaque reduction neutralization test (UTEP—PRNT) for 9 of 59 cord-blood plasma samples obtained from mothers at the Providence, Sierra East, Sierra Main hospitals, El Paso, Texas.
Median Fluorescence Intensity Values of samples reactive with West Nile virus envelope and/or West Nile and dengue virus (DEN) nonstructural antigens | UTEP PRNT80 Titers | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ELISA IgG Antibodies | WNV-E | WNV-NS1 | WNV-NS5 | Den 1 NS1 | Den 2 NS1 | Den 3 NS1 | Den 4 NS1 | NY—MIA | Antibody Titers | PRNT80 | |||
Sample Code | DENV | WNV | 232* | 212 | 6680 | 808 | 746 | 615 | 405 | Diagnosis antibody | DENV | WNV | Diagnosis antibody |
PMH0037 | 400 | 1600 | 1004 | 171 | 459 | 14 | 10 | 41.5 | 17 | Flavivirus Envelope | ≤20 | 320 | WNV |
PMH0167 | 1600 | 6400 | 5523 | 1048 | 1300 | 2498 | 2630 | 8207 | 2944 | WNV/DENV | ≤20 | 40 | WNV |
SES0146 | 400 | 100 | 737 | 262 | 2862 | 488 | 382 | 860 | 345 | Flavivirus Envelope | ≤20 | ≤20 | Neg |
SES0450 | 400 | 6400 | 364 | 81 | 629 | 19 | 29 | 20 | 19 | Flavivirus Envelope | ≤20 | 1280 | WNV |
SES0632 | 400 | 6400 | 620 | 179 | 504 | 19 | 15 | 62 | 31 | Flavivirus Envelope | ≤20 | 1280 | WNV |
SES0654 | 1600 | 6400 | 2343 | 249 | 1053 | 46 | 53 | 55 | 46 | WNV | DENV3 (160), DENV4 (640) | WNV (320) | WNV/DENV |
SES0827 | 1600 | 1600 | 273 | 53 | 658 | 273 | 113 | 461 | 78 | Flavivirus Envelope | ≤20 | 320 | WNV |
SMC0055 | 1600 | 1600 | 407 | 30 | 430 | 12 | 10 | 107 | 15 | Flavivirus Envelope | ≤20 | ≤20 | Neg |
SMC0119 | 200 | ≤100 | 851 | 33 | 331 | 564 | 149 | 310 | 71 | Flavivirus Envelope | ≤20 | ≤20 | Neg |
*- Median fluorescence intensity cut-off values for test samples equal to or higher representing antigen–antibody reactivity, ELISA cut-off values DENV IgG cut off = 0.24–0.29, WNV IgG cut off = 0.11–0.16, samples positive for both DENV and WNV antibodies with the same antibody titers or less than 4-fold difference = antibody positive to both viruses, virus with 4-fold or greater antibody titer considered antibody positive for the virus with the highest antibody titer. (7 flavivirus and 2 WN and/or DEN)